Dow Down 0.25% Nasdaq Down 0.14%

Pharmacyclics Inc. (PCYC)

-NasdaqGS
120.54 0.07(0.06%) Sep 29, 4:00PM EDT
Prev Close:120.61
Open:119.23
Bid:N/A
Ask:154.69 x 100
1y Target Est:157.88
Beta:1.12
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:118.42 - 123.39
52wk Range:82.51 - 154.89
Volume:612,495
Avg Vol (3m):972,377
Market Cap:9.07B
P/E (ttm):107.72
EPS (ttm):1.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
PCYCDown 0.06%9.07B
CTIC359.69M
MRK171.38B

Key Statistics

Forward P/E (1 yr):1,722.00
P/S (ttm):20.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.26
Quarterly EPS Est (Sep-14) :0.42
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2,899.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pharmacyclics, Inc., a biopharmaceutical company, designs, develops, and commercializes small-molecule drugs for the treatment of cancer and immune mediated diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback